marketcaparena
Search

    BVS

    Bioventus Inc.

    Company overview

    Market capitalization
    —
    Employees
    940
    Latest publication
    2026-09-29
    About Bioventus Inc.

    Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company's product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to treat chronic peripheral pain, and TalisMann provides stimulation to the targeted peripheral nerve, as well as XCELL PRP System, a benchtop device that processes whole blood to produce high-yield PRP with a 10-minute single-spin cycle. It also offers precision bone resection for patients with degenerative spine conditions and spinal deformities, as well as enables precision ultrasonic neuro and general surgery to address brain tumors and pathologies of the liver and other organs; and bone graft substitutes, including various products that facilitate optimal bone fusion. In addition, the company provides neXus, an ultrasonic surgical system; BoneScalpel, a surgical solution enabling precise cuts in hard tissue; BoneScalpel Access, for bone removal with visualization; SonaStar system, a precise ablation and removal of soft tissue; SonaStar Elite handpiece and accessories; SonicOne, an ultrasonic cleansing and debridement system; Osteoamp, an allograft-derived bone graft for orthopedic, neurosurgical, and reconstructive bone grafting procedures; Signafuse bone graft; Purebone, a natural osteoconductive scaffold; and Reficio demineralized bone matrix. The company's restorative therapies include minimally invasive fracture treatments and rehabilitation products. Its products also include Exogen, an ultrasound bone stimulation system. The company sells its products to healthcare institutions, physicians, patients, distributors and dealers. Bioventus Inc. was founded in 2011 and is headquartered in Durham, North Carolina.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-27 · USDQ1 20262026-03-31 · USDQ3 20252025-09-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ4 20202020-12-31 · USDQ3 20202020-09-30 · USD
    Total Revenue153,208,000USD132,089,000USD138,651,000USD123,876,000USD153,642,000USD138,964,000USD98,591,000USD85,908,000USD
    Cost Of Revenue47,542,000USD42,427,000USD45,820,000USD42,413,000USD50,986,000USD45,413,000USD25,121,000USD23,444,000USD
    Gross Profit105,666,000USD89,662,000USD92,831,000USD81,463,000USD102,656,000USD93,551,000USD73,470,000USD62,464,000USD
    Research Development3,173,000USD2,467,000USD2,923,000USD3,011,000USD3,246,000USD3,808,000USD2,891,000USD3,569,000USD
    Selling General Administrative82,740,000USD78,325,000USD78,657,000USD73,502,000USD86,613,000USD81,090,000USD59,205,000USD50,295,000USD
    Total Operating Expenses86,539,000USD80,773,000USD80,727,000USD76,490,000USD94,668,000USD89,477,000USD67,562,000USD55,531,000USD
    Operating Income19,127,000USD8,889,000USD12,104,000USD4,973,000USD7,988,000USD4,074,000USD5,908,000USD6,933,000USD
    Total Other Income Expense Net-3,819,000USD-4,372,000USD-7,434,000USD-8,390,000USD-7,756,000USD-8,906,000USD-2,767,000USD1,405,000USD
    Depreciation And Amortization1,041,000USD11,205,000USD11,403,000USD11,865,000USD12,405,000USD12,275,000USD6,854,000USD7,276,000USD
    Income Before Tax15,308,000USD4,517,000USD4,670,000USD-3,417,000USD232,000USD-4,832,000USD3,141,000USD8,338,000USD
    Income Tax Expense-20,897,000USD571,000USD664,000USD-95,000USD550,000USD589,000USD890,000USD373,000USD
    Net Income36,205,000USD3,113,000USD3,155,000USD-2,637,000USD-156,000USD-4,824,000USD2,776,000USD8,457,000USD
    Minority Interest2,764,000USD-833,000USD-851,000USD685,000USD162,000USD597,000USD1,919,000USD2,120,000USD
    Interest Expense—4,326,000USD6,177,000USD7,509,000USD8,997,000USD9,532,000USD2,656,000USD1,880,000USD
    Net Interest Income—-4,326,000USD-6,177,000USD-7,509,000USD-8,997,000USD-9,532,000USD-2,656,000USD-1,880,000USD
    Tax Provision—571,000USD664,000USD-95,000USD550,000USD589,000USD890,000USD373,000USD
    Net Income From Continuing Ops—3,946,000USD4,006,000USD-3,322,000USD-318,000USD-5,421,000USD2,251,000USD7,965,000USD
    Ebit—8,843,000USD10,847,000USD4,092,000USD9,229,000USD4,700,000USD5,797,000USD10,218,000USD
    Ebitda—20,048,000USD22,250,000USD15,957,000USD21,634,000USD16,975,000USD12,651,000USD17,494,000USD
    Reconciled Depreciation—11,205,000USD11,403,000USD11,865,000USD12,405,000USD12,275,000USD6,854,000USD7,276,000USD
    Unclassified Operating Expenses————4,809,000USD4,579,000USD2,697,000USD1,667,000USD
    Selling And Marketing Expenses——————2,769,000USD—
    Net Income Applicable To Common Shares——————498,000USD498,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20142014-12-31 · USD
    Total Revenue340,141,000USD319,177,000USD242,893,000USD
    Cost Of Revenue90,935,000USD84,168,000USD74,609,000USD
    Gross Profit249,206,000USD235,009,000USD168,284,000USD
    Research Development11,055,000USD8,095,000USD9,465,000USD
    Selling General Administrative196,124,000USD191,672,000USD—
    Selling And Marketing Expenses2,351,000USD——
    Unclassified Operating Expenses8,483,000USD9,738,000USD156,026,000USD
    Total Operating Expenses218,013,000USD209,505,000USD165,491,000USD
    Operating Income31,193,000USD25,504,000USD20,000USD
    Interest Expense21,579,000USD19,171,000USD11,969,000USD
    Net Interest Income-21,579,000USD-19,171,000USD—
    Income Before Tax9,689,000USD6,107,000USD-11,353,000USD
    Income Tax Expense1,576,000USD1,664,000USD1,547,000USD
    Tax Provision1,576,000USD1,664,000USD—
    Net Income6,851,000USD-12,207,000USD-12,900,000USD
    Net Income From Continuing Ops8,113,000USD4,443,000USD—
    Ebit31,268,000USD25,278,000USD482,000USD
    Ebitda61,584,000USD54,516,000USD29,302,000USD
    Depreciation And Amortization30,316,000USD29,238,000USD28,820,000USD
    Reconciled Depreciation30,316,000USD29,238,000USD—
    Total Other Income Expense Net-21,504,000USD-19,397,000USD-11,373,000USD
    Minority Interest2,635,000USD2,635,000USD—
    Discontinued Operations-1,815,000USD-16,650,000USD—
    Net Income Applicable To Common Shares-659,000USD-17,988,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-27 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets673,346,000USD650,539,000USD683,559,000USD701,593,000USD706,788,000USD691,414,000USD727,956,000USD769,492,000USD
    Cash And Equivalents29,457,000USD———————
    Long Term Investments3,507,000USD———————
    Total Current Assets257,527,000USD249,813,000USD272,842,000USD280,901,000USD275,203,000USD249,367,000USD275,610,000USD298,688,000USD
    Other Current Assets9,857,000USD10,255,000USD11,065,000USD12,060,000USD13,461,000USD14,438,000USD14,160,000USD43,657,000USD
    Total Liabilities395,934,000USD———————
    Total Current Liabilities152,451,000USD148,095,000USD160,380,000USD161,752,000USD185,680,000USD174,751,000USD210,398,000USD211,492,000USD
    Other Current Liabilities4,144,000USD———————
    Other Non Current Liabilities13,213,000USD———————
    Total Stockholder Equity228,306,000USD188,901,000USD184,105,000USD166,096,000USD161,242,000USD148,144,000USD147,940,000USD148,738,000USD
    Total Equity Including Noncontrolling Interest277,412,000USD———————
    Short Long Term Debt18,750,000USD18,750,000USD15,000,000USD11,250,000USD43,358,000USD37,339,000USD27,339,000USD38,566,000USD
    Long Term Debt229,702,000USD253,326,000USD278,951,000USD311,334,000USD297,880,000USD308,593,000USD308,288,000USD345,021,000USD
    Net Receivables138,406,000USD120,525,000USD128,303,000USD130,404,000USD132,367,000USD118,082,000USD127,393,000USD121,925,000USD
    Inventory79,807,000USD83,187,000USD82,236,000USD96,273,000USD96,465,000USD94,045,000USD92,475,000USD90,032,000USD
    Property Plant Equipment Net24,752,000USD25,981,000USD27,021,000USD28,813,000USD30,737,000USD32,353,000USD33,518,000USD39,204,000USD
    Goodwill7,462,000USD———————
    Intangible Assets351,046,000USD359,659,000USD368,419,000USD377,398,000USD386,954,000USD395,731,000USD404,729,000USD414,809,000USD
    Accounts Payable20,196,000USD24,050,000USD10,928,000USD26,649,000USD24,245,000USD19,197,000USD23,690,000USD16,849,000USD
    Retained Earnings-298,375,000USD-331,816,000USD-334,929,000USD-349,684,000USD-352,839,000USD-360,298,000USD-355,078,000USD-354,922,000USD
    Accumulated Other Comprehensive Income-1,328,000USD-2,279,000USD-1,900,000USD-1,837,000USD-774,000USD-2,062,000USD-2,573,000USD445,000USD
    Total Liab—416,274,000USD455,112,000USD494,338,000USD505,489,000USD505,935,000USD542,352,000USD582,659,000USD
    Other Current Liab—105,295,000USD130,242,000USD123,853,000USD113,433,000USD112,080,000USD155,501,000USD149,930,000USD
    Common Stock—84,000USD83,000USD83,000USD83,000USD82,000USD82,000USD81,000USD
    Capital Stock—84,000USD83,000USD83,000USD83,000USD82,000USD82,000USD81,000USD
    Good Will—7,462,000USD7,462,000USD7,462,000USD7,462,000USD7,462,000USD7,462,000USD7,462,000USD
    Cash—35,846,000USD51,238,000USD42,164,000USD32,910,000USD22,802,000USD41,582,000USD43,074,000USD
    Cash And Short Term Investments—35,846,000USD51,238,000USD42,164,000USD32,910,000USD22,802,000USD41,582,000USD43,074,000USD
    Net Debt—236,230,000USD260,108,000USD280,420,000USD308,328,000USD323,130,000USD294,045,000USD340,513,000USD
    Short Term Debt—18,750,000USD19,210,000USD11,250,000USD43,358,000USD37,339,000USD27,339,000USD38,566,000USD
    Short Long Term Debt Total—272,076,000USD311,346,000USD322,584,000USD341,238,000USD345,932,000USD335,627,000USD383,587,000USD
    Property Plant Equipment Gross—25,981,000USD81,285,000USD28,813,000USD30,737,000USD32,353,000USD83,704,000USD87,670,000USD
    Common Stock Shares Outstanding—70,008,291shares68,914,895shares68,837,797shares68,536,759shares66,008,683shares65,451,881shares65,258,427shares
    Non Current Assets Total—400,726,000USD410,717,000USD420,692,000USD431,585,000USD442,047,000USD452,346,000USD470,804,000USD
    Non Current Liabilities Total—268,179,000USD294,732,000USD332,586,000USD319,809,000USD331,184,000USD331,954,000USD371,167,000USD
    Non Current Liabilities Other—14,285,000USD15,348,000USD20,466,000USD21,278,000USD21,984,000USD23,102,000USD26,146,000USD
    Non Currrent Assets Other—2,102,000USD2,293,000USD2,274,000USD1,687,000USD1,756,000USD1,892,000USD1,933,000USD
    Net Working Capital—101,718,000USD112,462,000USD119,149,000USD89,523,000USD74,616,000USD65,212,000USD87,196,000USD
    Unclassified Non Current Assets—5,522,000USD5,522,000USD4,745,000USD4,745,000USD4,745,000USD4,745,000USD7,396,000USD
    Unclassified Current Liabilities—-18,750,000USD-15,000,000USD-11,250,000USD-38,714,000USD-31,204,000USD-23,471,000USD-32,419,000USD
    Unclassified Equity—522,828,000USD520,768,000USD517,451,000USD514,689,000USD510,340,000USD505,427,000USD503,053,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets683,559,000USD727,956,000USD810,910,000USD1,372,649,000USD1,225,862,000USD494,466,000USD472,407,000USD442,723,000USD
    Intangible Assets368,419,000USD404,729,000USD482,350,000USD639,851,000USD695,193,000USD191,650,000USD216,510,000USD237,029,000USD
    Other Current Assets11,065,000USD14,160,000USD16,913,000USD21,328,000USD32,519,000USD7,552,000USD6,059,000USD5,143,000USD
    Total Liab455,112,000USD542,352,000USD589,792,000USD960,427,000USD692,073,000USD350,306,000USD326,790,000USD297,456,000USD
    Total Stockholder Equity184,105,000USD147,940,000USD173,591,000USD325,238,000USD458,924,000USD142,241,000USD142,982,000USD145,267,000USD
    Other Current Liab130,242,000USD155,501,000USD119,862,000USD231,692,000USD137,767,000USD100,733,000USD70,020,000USD49,939,000USD
    Common Stock83,000USD82,000USD79,000USD78,000USD75,000USD285,173,000USD285,147,000USD285,153,000USD
    Capital Stock83,000USD82,000USD79,000USD78,000USD75,000USD285,173,000USD285,147,000USD285,153,000USD
    Retained Earnings-334,929,000USD-355,078,000USD-321,536,000USD-165,306,000USD-6,602,000USD-144,539,000USD-141,700,000USD-139,821,000USD
    Good Will7,462,000USD7,462,000USD7,462,000USD7,462,000USD147,623,000USD49,800,000USD49,800,000USD49,800,000USD
    Cash51,238,000USD41,582,000USD36,964,000USD30,186,000USD43,933,000USD86,839,000USD64,520,000USD42,774,000USD
    Cash And Short Term Investments51,238,000USD41,582,000USD36,964,000USD30,186,000USD43,933,000USD86,839,000USD64,520,000USD42,774,000USD
    Total Current Assets272,842,000USD275,610,000USD267,999,000USD272,575,000USD263,103,000USD211,794,000USD183,033,000USD148,354,000USD
    Total Current Liabilities160,380,000USD210,398,000USD175,497,000USD304,017,000USD180,859,000USD122,589,000USD89,015,000USD65,428,000USD
    Net Debt260,108,000USD294,045,000USD357,882,000USD387,880,000USD313,749,000USD101,539,000USD133,445,000USD152,054,000USD
    Short Term Debt19,210,000USD27,339,000USD27,848,000USD33,056,000USD18,038,000USD15,000,000USD10,000,000USD5,250,000USD
    Short Long Term Debt15,000,000USD27,339,000USD27,848,000USD33,056,000USD18,038,000USD15,000,000USD10,000,000USD5,250,000USD
    Short Long Term Debt Total311,346,000USD335,627,000USD394,846,000USD418,066,000USD357,682,000USD188,378,000USD197,965,000USD194,828,000USD
    Long Term Debt278,951,000USD308,288,000USD366,998,000USD385,010,000USD339,644,000USD173,378,000USD187,965,000USD189,578,000USD
    Net Receivables128,303,000USD127,393,000USD122,789,000USD136,295,000USD124,963,000USD88,283,000USD85,128,000USD73,041,000USD
    Inventory82,236,000USD92,475,000USD91,333,000USD84,766,000USD61,688,000USD29,120,000USD27,326,000USD27,396,000USD
    Accounts Payable10,928,000USD23,690,000USD23,038,000USD36,697,000USD16,915,000USD4,422,000USD6,440,000USD8,207,000USD
    Property Plant Equipment Net27,021,000USD33,518,000USD49,958,000USD44,146,000USD40,171,000USD21,840,000USD19,756,000USD4,759,000USD
    Property Plant Equipment Gross81,285,000USD83,704,000USD90,462,000USD44,955,000USD40,171,000USD21,840,000USD19,756,000USD4,759,000USD
    Accumulated Other Comprehensive Income-1,900,000USD-2,573,000USD794,000USD-110,000USD179,000USD1,607,000USD-465,000USD-65,000USD
    Common Stock Shares Outstanding68,914,895shares65,355,154shares62,647,554shares61,389,107shares45,472,483shares37,697,158shares56,825,325shares56,825,325shares
    Non Current Assets Total410,717,000USD452,346,000USD542,911,000USD1,100,074,000USD962,759,000USD282,672,000USD289,374,000USD294,369,000USD
    Non Current Liabilities Total294,732,000USD331,954,000USD414,295,000USD656,410,000USD511,214,000USD227,717,000USD237,775,000USD232,028,000USD
    Non Current Liabilities Other15,348,000USD23,102,000USD46,084,000USD110,020,000USD38,052,000USD21,728,000USD20,681,000USD5,432,000USD
    Non Currrent Assets Other2,293,000USD1,892,000USD3,141,000USD405,979,000USD50,000,000USD19,382,000USD3,308,000USD2,781,000USD
    Net Working Capital112,462,000USD65,212,000USD92,502,000USD-31,442,000USD82,244,000USD89,205,000USD94,018,000USD82,926,000USD
    Unclassified Non Current Assets5,522,000USD4,745,000USD——-50,000,000USD-53,725,000USD-3,308,000USD—
    Unclassified Current Liabilities-15,000,000USD-23,471,000USD-27,848,000USD-30,484,000USD-152,247,000USD-111,807,000USD-64,401,000USD-43,350,000USD
    Unclassified Equity520,768,000USD505,427,000USD494,175,000USD490,498,000USD465,197,000USD-285,173,000USD-285,147,000USD-285,153,000USD
    Current Deferred Revenue——4,749,000USD—142,348,000USD99,241,000USD56,956,000USD40,132,000USD
    Long Term Investments———2,636,000USD29,291,000USD19,382,000USD3,308,000USD2,781,000USD
    Unclassified Non Current Liabilities———161,380,000USD-171,570,000USD-7,620,000USD-6,168,000USD-5,432,000USD
    Deferred Long Term Liab————133,518,000USD———
    Other Liab————171,570,000USD40,231,000USD35,297,000USD42,450,000USD
    Other Assets————50,481,000USD34,343,000USD——
    Net Tangible Assets————-383,892,000USD-267,209,000USD-291,328,000USD-309,562,000USD
    Short Term Investments—————19,382,000USD——
    Unclassified Current Assets—————-19,382,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income3,946,000USD17,318,000USD4,006,000USD9,272,000USD-3,322,000USD-318,000USD-5,421,000USD-23,992,000USD
    Depreciation11,205,000USD11,694,000USD11,403,000USD12,049,000USD11,865,000USD12,405,000USD12,275,000USD13,090,000USD
    Stock Based Compensation3,264,000USD3,440,000USD3,176,000USD3,643,000USD2,414,000USD1,731,000USD2,064,000USD3,672,000USD
    Other Non Cash Items559,000USD440,000USD701,000USD453,000USD870,000USD4,397,000USD2,367,000USD25,028,000USD
    Change To Account Receivables7,318,000USD1,885,000USD1,824,000USD-13,629,000USD9,004,000USD-5,792,000USD17,059,000USD-19,975,000USD
    Change To Inventory-2,648,000USD12,968,000USD291,000USD-2,809,000USD-1,881,000USD-5,561,000USD-2,515,000USD-4,289,000USD
    Change In Working Capital-10,175,000USD6,207,000USD10,677,000USD477,000USD-31,201,000USD-2,108,000USD-458,000USD5,543,000USD
    Total Cash From Operating Activities8,934,000USD37,968,000USD30,098,000USD25,938,000USD-19,331,000USD19,322,000USD10,316,000USD15,162,000USD
    Capital Expenditures-574,000USD-580,000USD-473,000USD-683,000USD-826,000USD-574,000USD-64,000USD-77,000USD
    Free Cash Flow8,359,999USD37,388,000USD29,625,000USD25,255,000USD-20,157,000USD18,748,000USD10,252,000USD15,085,000USD
    Total Cashflows From Investing Activities-574,000USD-580,000USD-473,000USD-1,369,000USD-826,000USD24,104,000USD-64,000USD-77,000USD
    Net Borrowings-22,000,000USD-28,750,000USD-19,160,000USD-5,000,000USD10,000,000USD-48,264,000USD0USD—
    Total Cash From Financing Activities-23,144,000USD-28,447,000USD-19,977,000USD-14,663,000USD947,000USD-42,855,000USD362,000USD-7,845,000USD
    Issuance Of Capital Stock120,000USD511,000USD96,000USD1,317,000USD150,000USD1,103,000USD553,000USD609,000USD
    Change In Cash-15,392,000USD9,074,000USD9,254,000USD10,108,000USD-18,780,000USD-1,492,000USD11,080,000USD6,821,000USD
    Begin Period Cash Flow51,238,000USD42,164,000USD32,910,000USD22,802,000USD41,582,000USD43,074,000USD31,994,000USD25,173,000USD
    End Period Cash Flow35,846,000USD51,238,000USD42,164,000USD32,910,000USD22,802,000USD41,582,000USD43,074,000USD31,994,000USD
    Other Cashflows From Financing Activities-1,264,000USD-208,000USD-913,000USD-10,980,000USD-9,203,000USD4,306,000USD-191,000USD-190,000USD
    Investments—0USD-473,000USD-1,369,000USD-826,000USD24,104,000USD-64,000USD-77,000USD
    Unclassified Operating Cash Flow—-1,131,000USD———3,215,000USD—-8,179,000USD
    Other Cashflows From Investing Activities———-686,000USD—24,678,000USD-709,000USD—
    Unclassified Investing Cash Flow———1,369,000USD—-24,104,000USD——
    Unclassified Financing Cash Flow———————-8,264,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20152015-12-31 · USDFY 20142014-12-31 · USD
    Net Income27,274,000USD-318,000USD-121,196,000USD-144,651,000USD9,586,000USD14,722,000USD-34,111,000USD-12,900,000USD
    Depreciation47,011,000USD49,555,000USD57,365,000USD55,398,000USD34,875,000USD28,643,000USD33,078,000USD28,820,000USD
    Stock Based Compensation12,673,000USD10,058,000USD2,722,000USD17,585,000USD-4,512,000USD10,103,000USD3,325,000USD2,355,000USD
    Other Non Cash Items1,767,000USD-3,326,000USD82,011,000USD134,519,000USD6,075,000USD3,534,000USD31,032,000USD11,896,000USD
    Change To Account Receivables-916,000USD-10,666,000USD10,055,000USD-17,672,000USD-20,052,000USD-3,941,000USD-11,266,000USD-217,000USD
    Change To Inventory8,569,000USD-16,435,000USD-5,991,000USD-18,618,000USD3,183,000USD-528,000USD-5,729,000USD10,649,000USD
    Change In Working Capital-13,840,000USD-11,780,000USD-3,181,000USD-29,730,000USD-13,277,000USD15,308,000USD-10,647,000USD-12,006,000USD
    Total Cash From Operating Activities73,976,000USD38,795,000USD15,344,000USD-13,537,000USD22,991,000USD71,799,000USD18,920,000USD15,109,000USD
    Capital Expenditures-2,562,000USD-1,006,000USD-7,362,000USD-1,478,000USD-7,370,000USD-20,672,000USD-7,442,000USD-20,830,000USD
    Free Cash Flow71,414,000USD37,789,000USD7,982,000USD-15,015,000USD15,621,000USD51,127,000USD11,478,000USD-5,721,000USD
    Investments0USD22,963,000USD12,995,000USD-116,436,000USD-13,520,000USD-20,500,000USD——
    Total Cashflows From Investing Activities-3,248,000USD22,963,000USD15,807,000USD-116,436,000USD-283,760,000USD-20,500,000USD-60,185,000USD-31,376,000USD
    Net Borrowings-42,910,000USD-59,584,000USD-23,264,000USD59,621,000USD166,203,000USD-10,000,000USD-675,000USD—
    Total Cash From Financing Activities-61,443,000USD-54,580,000USD-26,653,000USD62,076,000USD273,371,000USD-29,569,000USD31,246,000USD-6,645,000USD
    Issuance Of Capital Stock2,074,000USD2,442,000USD1,703,000USD5,822,000USD109,410,000USD0USD——
    Change In Cash9,656,000USD4,618,000USD5,127,000USD-67,376,000USD12,374,000USD22,319,000USD-10,824,000USD-24,340,000USD
    Begin Period Cash Flow41,582,000USD36,964,000USD31,837,000USD99,213,000USD86,839,000USD64,520,000USD15,774,000USD40,114,000USD
    End Period Cash Flow51,238,000USD41,582,000USD36,964,000USD31,837,000USD99,213,000USD86,839,000USD4,950,000USD15,774,000USD
    Other Cashflows From Investing Activities-3,248,000USD23,969,000USD-11,506,000USD-114,958,000USD-262,870,000USD172,000USD-6,608,000USD-19,668,000USD
    Other Cashflows From Financing Activities-20,606,999USD2,562,000USD-4,167,000USD-3,367,000USD-1,875,000USD49,317,000USD32,937,000USD-1,731,000USD
    Unclassified Investing Cash Flow2,562,000USD-22,963,000USD21,680,000USD116,436,000USD—20,500,000USD-46,135,000USD9,122,000USD
    Unclassified Operating Cash Flow—-5,394,000USD-2,377,000USD-46,658,000USD-9,756,000USD—-3,757,000USD-3,056,000USD
    Dividends Paid———-3,352,000USD-367,000USD-19,886,000USD-1,016,000USD-2,399,000USD
    Sale Purchase Of Stock———-3,352,000USD277,453,000USD———
    Unclassified Financing Cash Flow———12,526,000USD-168,043,000USD-49,000,000USD—-2,515,000USD
    Change To Liabilities————18,211,000USD20,510,000USD5,182,000USD—
    Cash And Cash Equivalents Changes————12,602,000USD———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-27GeographyInternational18,743,000USDDisclosure
    Q2 2026Quarterly · 2026-06-27GeographyUnited States134,465,000USDDisclosure
    Q2 2026Quarterly · 2026-06-27SegmentInternational18,743,000USDDisclosure
    Q2 2026Quarterly · 2026-06-27SegmentUS134,465,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31GeographyInternational15,644,000USD0001665988-26-000027
    Q1 2026Quarterly · 2026-03-31GeographyUnited States116,445,000USD0001665988-26-000027
    Q1 2026Quarterly · 2026-03-31SegmentInternational15,644,000USD0001665988-26-000027
    Q1 2026Quarterly · 2026-03-31SegmentUS116,445,000USD0001665988-26-000027
    Q4 2025Quarterly · 2025-12-31GeographyInternational18,412,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyUnited States139,488,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentInternational18,412,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentUS139,488,000USDLegacy provider
    FY 2025Yearly · 2025-12-31GeographyInternational65,990,000USD0001665988-26-000011
    FY 2025Yearly · 2025-12-31GeographyUnited States502,097,000USD0001665988-26-000011
    FY 2025Yearly · 2025-12-31SegmentInternational65,990,000USD0001665988-26-000011
    FY 2025Yearly · 2025-12-31SegmentUS502,097,000USD0001665988-26-000011
    Q3 2025Quarterly · 2025-09-30GeographyInternational15,337,000USD0001665988-25-000026
    Q3 2025Quarterly · 2025-09-30GeographyUnited States123,314,000USD0001665988-25-000026
    Q3 2025Quarterly · 2025-09-30SegmentInternational15,337,000USD0001665988-25-000026
    Q3 2025Quarterly · 2025-09-30SegmentUS123,314,000USD0001665988-25-000026
    Q2 2025Quarterly · 2025-06-30GeographyInternational18,885,000USD0001665988-25-000017
    Q2 2025Quarterly · 2025-06-30GeographyUnited States128,775,000USD0001665988-25-000017
    Q2 2025Quarterly · 2025-06-30SegmentInternational18,885,000USD0001665988-25-000017
    Q2 2025Quarterly · 2025-06-30SegmentUS128,775,000USD0001665988-25-000017
    Q1 2025Quarterly · 2025-03-31GeographyInternational13,356,000USD0001665988-26-000027
    Q1 2025Quarterly · 2025-03-31GeographyUnited States110,520,000USD0001665988-26-000027
    Q1 2025Quarterly · 2025-03-31SegmentInternational13,356,000USD0001665988-26-000027
    Q1 2025Quarterly · 2025-03-31SegmentUS110,520,000USD0001665988-26-000027
    Q4 2024Quarterly · 2024-12-31GeographyInternational18,432,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyUnited States135,210,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentInternational18,432,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentUS135,210,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyInternational66,471,000USD0001665988-26-000011
    FY 2024Yearly · 2024-12-31GeographyUnited States506,809,000USD0001665988-26-000011
    FY 2024Yearly · 2024-12-31SegmentInternational66,471,000USD0001665988-26-000011
    FY 2024Yearly · 2024-12-31SegmentUS506,809,000USD0001665988-26-000011
    Q3 2024Quarterly · 2024-09-30GeographyInternational16,055,000USD0001665988-25-000026
    Q3 2024Quarterly · 2024-09-30GeographyUnited States122,909,000USD0001665988-25-000026
    Q3 2024Quarterly · 2024-09-30SegmentInternational16,055,000USD0001665988-25-000026
    Q3 2024Quarterly · 2024-09-30SegmentUS122,909,000USD0001665988-25-000026
    FY 2023Yearly · 2023-12-31GeographyInternational62,485,000USD0001665988-26-000011
    FY 2023Yearly · 2023-12-31GeographyUnited States449,860,000USD0001665988-26-000011
    FY 2023Yearly · 2023-12-31SegmentInternational62,485,000USD0001665988-26-000011
    FY 2023Yearly · 2023-12-31SegmentUS449,860,000USD0001665988-26-000011
    FY 2022Yearly · 2022-12-31GeographyInternational56,866,000USD0001628280-25-011831
    FY 2022Yearly · 2022-12-31GeographyUnited States455,251,000USD0001628280-25-011831
    FY 2022Yearly · 2022-12-31SegmentInternational56,866,000USD0001628280-25-011831
    FY 2022Yearly · 2022-12-31SegmentUS455,251,000USD0001628280-25-011831
    Q2 2022Quarterly · 2022-06-30ProductPain Treatments63,914,000USD0001628280-22-022592
    Q2 2022Quarterly · 2022-06-30ProductRestorative Therapies39,902,000USD0001628280-22-022592
    Q2 2022Quarterly · 2022-06-30ProductSurgical Solutions36,515,000USD0001628280-22-022592
    Q1 2022Quarterly · 2022-03-31ProductPain Treatments52,053,000USD0001628280-22-013756
    Q1 2022Quarterly · 2022-03-31ProductRestorative Therapies34,360,000USD0001628280-22-013756
    Q1 2022Quarterly · 2022-03-31ProductSurgical Solutions30,877,000USD0001628280-22-013756
    FY 2021Yearly · 2021-12-31GeographyInternational43,345,000USD0001628280-24-010376
    FY 2021Yearly · 2021-12-31GeographyUnited States387,553,000USD0001628280-24-010376
    FY 2021Yearly · 2021-12-31ProductPain Treatments221,607,000USD0001628280-22-005816
    FY 2021Yearly · 2021-12-31ProductRestorative Therapies121,572,000USD0001628280-22-005816
    FY 2021Yearly · 2021-12-31ProductSurgical Solutions87,719,000USD0001628280-22-005816
    Q3 2021Quarterly · 2021-09-30ProductBone Graft Substitutes17,780,000USD0001628280-21-022681
    Q3 2021Quarterly · 2021-09-30ProductPain Treatments And Joint Preservation60,635,000USD0001628280-21-022681
    Q3 2021Quarterly · 2021-09-30ProductRestorative Therapies30,475,000USD0001628280-21-022681
    Q2 2021Quarterly · 2021-06-30ProductPain Treatments56,704,000USD0001628280-22-022592
    Q2 2021Quarterly · 2021-06-30ProductRestorative Therapies32,511,000USD0001628280-22-022592
    Q2 2021Quarterly · 2021-06-30ProductSurgical Solutions20,601,000USD0001628280-22-022592
    Q1 2021Quarterly · 2021-03-31ProductPain Treatments41,530,000USD0001628280-22-013756
    Q1 2021Quarterly · 2021-03-31ProductRestorative Therapies21,821,000USD0001628280-22-013756
    Q1 2021Quarterly · 2021-03-31ProductSurgical Solutions18,427,000USD0001628280-22-013756
    FY 2020Yearly · 2020-12-31GeographyInternational27,464,000USD0001628280-23-010151
    FY 2020Yearly · 2020-12-31GeographyUnited States293,697,000USD0001628280-23-010151
    FY 2020Yearly · 2020-12-31ProductPain Treatments171,178,000USD0001628280-22-005816
    FY 2020Yearly · 2020-12-31ProductRestorative Therapies88,624,000USD0001628280-22-005816
    FY 2020Yearly · 2020-12-31ProductSurgical Solutions61,359,000USD0001628280-22-005816
    Q3 2020Quarterly · 2020-09-30ProductBone Graft Substitutes17,127,000USD0001628280-21-022681
    Q3 2020Quarterly · 2020-09-30ProductPain Treatments And Joint Preservation48,781,000USD0001628280-21-022681
    Q3 2020Quarterly · 2020-09-30ProductRestorative Therapies20,000,000USD0001628280-21-022681
    Q2 2020Quarterly · 2020-06-30ProductBone Graft Substitutes11,181,000USD0001628280-21-016502
    Q2 2020Quarterly · 2020-06-30ProductPain Treatments And Joint Preservation28,868,000USD0001628280-21-016502
    Q2 2020Quarterly · 2020-06-30ProductRestorative Therapies17,968,000USD0001628280-21-016502
    Q1 2020Quarterly · 2020-03-31ProductBone Graft Substitutes13,897,000USD0001628280-21-010090
    Q1 2020Quarterly · 2020-03-31ProductPain Treatments And Joint Preservation41,283,000USD0001628280-21-010090
    Q1 2020Quarterly · 2020-03-31ProductRestorative Therapies23,465,000USD0001628280-21-010090
    FY 2019Yearly · 2019-12-31GeographyInternational35,069,000USD0001628280-22-005816
    FY 2019Yearly · 2019-12-31GeographyUnited States305,072,000USD0001628280-22-005816
    FY 2019Yearly · 2019-12-31ProductPain Treatments182,082,000USD0001628280-22-005816
    FY 2019Yearly · 2019-12-31ProductRestorative Therapies103,504,000USD0001628280-22-005816
    FY 2019Yearly · 2019-12-31ProductSurgical Solutions54,555,000USD0001628280-22-005816

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.